Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
P/S ratio for Collegium Pharmaceutical (COLL)
P/S ratio as of April 2024 (TTM): 2.10
According to Collegium Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.1028. At the end of 2023 the company had a P/S ratio of 1.77.
P/S ratio history for Collegium Pharmaceutical from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.77 | 5.49% |
| 2022 | 1.68 | -28.02% |
| 2021 | 2.33 | 4.38% |
| 2020 | 2.23 | -4.35% |
| 2019 | 2.34 | 14.69% |
| 2018 | 2.04 | -90.35% |
| 2017 | 21.1 | -91.89% |
| 2016 | 260 | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | 4.73 | 124.85% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | 0.1400 | -93.34% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 7.31 | 247.52% | 🇮🇪 Ireland |
 KemPharm KMPH | 19.2 | 811.61% | 🇺🇸 USA |